The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Axsome Therapeutics Inc | COM | 05464T104 | 41,492 | 1,611,329 | SH | SOLE | 1,611,329 | 0 | 0 | ||
Bellerophon Therapeutics | COM | 078771102 | 1,450 | 2,417,227 | SH | SOLE | 2,417,227 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COM | 09058V103 | 10,264 | 2,708,207 | SH | SOLE | 2,708,207 | 0 | 0 | ||
Constellation Pharmaceuticals | COM | 210373106 | 819 | 66,667 | SH | SOLE | 66,667 | 0 | 0 | ||
Gemphire Therapeutics | COM | 36870A108 | 646 | 798,066 | SH | SOLE | 798,066 | 0 | 0 | ||
Kadmon Holdings Inc. | COM | 48283N106 | 870 | 422,141 | SH | SOLE | 422,141 | 0 | 0 | ||
Kalvista Pharmaceuticals | COM | 483497103 | 14,129 | 637,884 | SH | SOLE | 637,884 | 0 | 0 | ||
Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | 4,229 | 312,320 | SH | SOLE | 312,320 | 0 | 0 | ||
La Jolla Pharmaceuticals | COM | 503459604 | 11,580 | 1,251,898 | SH | SOLE | 1,251,898 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COM | 56854Q101 | 5,225 | 1,258,964 | SH | SOLE | 1,258,964 | 0 | 0 | ||
Milestone Pharmaceuticals Inc | COM | 59935V107 | 56,106 | 2,066,529 | SH | SOLE | 2,066,529 | 0 | 0 | ||
Obseva SA | COM | H5861P103 | 13,117 | 1,159,789 | SH | SOLE | 1,159,789 | 0 | 0 | ||
Orchard RX Ltd | COM | 68570P101 | 9,461 | 676,252 | SH | SOLE | 676,252 | 0 | 0 | ||
Protagonist Therapeutics Inc | COM | 74366E102 | 12,986 | 1,072,348 | SH | SOLE | 1,072,348 | 0 | 0 | ||
Proteostasis Therapeutics Inc | COM | 74373B109 | 216 | 221,267 | SH | SOLE | 221,267 | 0 | 0 | ||
Ra Pharmaceuticals | COM | 74933V108 | 20,157 | 670,350 | SH | SOLE | 670,350 | 0 | 0 | ||
Tricida Inc | COM | 89610F101 | 11,433 | 289,746 | SH | SOLE | 289,746 | 0 | 0 |